Posterior reversible encephalopathy syndrome in a patient with lupus nephritis on rituximab therapy: a challenge to find the offender.

Mondal, S; Goswami, R Prosad; Sinha, D; Basu, K; Das, S; Ghosh, P; Ghosh, A

Mondal, S; Goswami, R Prosad; Sinha, D; Basu, K; Das, S; Ghosh, P; Ghosh, A.

Afiliação

Mondal S; Department of Rheumatology, Institute of Post Graduate Medical Education and Research, Kolkata, India drmsumantro@gmail.com.
Goswami RP; Department of Rheumatology, Institute of Post Graduate Medical Education and Research, Kolkata, India.
Sinha D; Department of Rheumatology, Institute of Post Graduate Medical Education and Research, Kolkata, India.
Basu K; Department of Rheumatology, Institute of Post Graduate Medical Education and Research, Kolkata, India.
Das S; Department of Rheumatology, Institute of Post Graduate Medical Education and Research, Kolkata, India.
Ghosh P; Department of Rheumatology, Institute of Post Graduate Medical Education and Research, Kolkata, India.
Ghosh A; Department of Rheumatology, Institute of Post Graduate Medical Education and Research, Kolkata, India.

Lupus ; 25(4): 445-6, 2016 Apr.

Article em En | MEDLINE | ID: mdl-26405025

Assuntos

Imunossupressores/efeitos adversos; Nefrite Lúpica/tratamento farmacológico; Síndrome da Leucoencefalopatia Posterior/induzido quimicamente; Rituximab/efeitos adversos; Adolescente; Feminino; Humanos; Nefrite Lúpica/diagnóstico; Nefrite Lúpica/imunologia; Imageamento por Ressonância Magnética; Síndrome da Leucoencefalopatia Posterior/diagnóstico; Fatores de Risco

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nefrite Lúpica / Síndrome da Leucoencefalopatia Posterior / Rituximab / Imunossupressores Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Adolescent / Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google